A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy

Conditions: Diabetic Retinopathy Interventions: Drug: BI 764524; Drug: Sham comparator to BI 764524; Drug: Aflibercept (Eylea ®) - US only Sponsors: Boehringer Ingelheim Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials